373 related articles for article (PubMed ID: 25148176)
41. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up.
Jackman RJ; Nowels KW; Rodriguez-Soto J; Marzoni FA; Finkelstein SI; Shepard MJ
Radiology; 1999 Mar; 210(3):799-805. PubMed ID: 10207484
[TBL] [Abstract][Full Text] [Related]
42. JOURNAL CLUB: Is screening MRI indicated for women with a personal history of breast cancer? Analysis based on biopsy results.
Arazi-Kleinman T; Skair-Levy M; Slonimsky E; Maly B; Uziely B; Libson E; Sella T
AJR Am J Roentgenol; 2013 Oct; 201(4):919-27. PubMed ID: 24059385
[TBL] [Abstract][Full Text] [Related]
43. Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI?
Linda A; Zuiani C; Furlan A; Lorenzon M; Londero V; Girometti R; Bazzocchi M
AJR Am J Roentgenol; 2012 Feb; 198(2):272-80. PubMed ID: 22268168
[TBL] [Abstract][Full Text] [Related]
44. Papillary lesions on core breast biopsy: excisional biopsy for all patients?
McGhan LJ; Pockaj BA; Wasif N; Giurescu ME; McCullough AE; Gray RJ
Am Surg; 2013 Dec; 79(12):1238-42. PubMed ID: 24351348
[TBL] [Abstract][Full Text] [Related]
45. Columnar cell lesions without atypia initially diagnosed on breast needle biopsies: is imaging follow-up enough?
Seo M; Chang JM; Kim WH; Park IA; Lee SH; Cho N; Moon WK
AJR Am J Roentgenol; 2013 Oct; 201(4):928-34. PubMed ID: 24059386
[TBL] [Abstract][Full Text] [Related]
46. Complete excision of the MRI target lesion at MRI-guided vacuum-assisted biopsy of breast cancer.
Lee JM; Kaplan JB; Murray MP; Liberman L
AJR Am J Roentgenol; 2008 Oct; 191(4):1198-202. PubMed ID: 18806165
[TBL] [Abstract][Full Text] [Related]
47. Imaging features and management of high-risk lesions on contrast-enhanced dynamic breast MRI.
Heller SL; Moy L
AJR Am J Roentgenol; 2012 Feb; 198(2):249-55. PubMed ID: 22268165
[TBL] [Abstract][Full Text] [Related]
48. Papillary lesions initially diagnosed at ultrasound-guided vacuum-assisted breast biopsy: rate of malignancy based on subsequent surgical excision.
Chang JM; Han W; Moon WK; Cho N; Noh DY; Park IA; Jung EJ
Ann Surg Oncol; 2011 Sep; 18(9):2506-14. PubMed ID: 21369740
[TBL] [Abstract][Full Text] [Related]
49. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions?
Masood S; Loya A; Khalbuss W
Diagn Cytopathol; 2003 Jun; 28(6):329-34. PubMed ID: 12768640
[TBL] [Abstract][Full Text] [Related]
50. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Brennan ME; Turner RM; Ciatto S; Marinovich ML; French JR; Macaskill P; Houssami N
Radiology; 2011 Jul; 260(1):119-28. PubMed ID: 21493791
[TBL] [Abstract][Full Text] [Related]
51. Flat epithelial atypia and atypical ductal hyperplasia: carcinoma underestimation rate.
Ingegnoli A; d'Aloia C; Frattaruolo A; Pallavera L; Martella E; Crisi G; Zompatori M
Breast J; 2010; 16(1):55-9. PubMed ID: 19825003
[TBL] [Abstract][Full Text] [Related]
52. Clinical experience with MRI-guided vacuum-assisted breast biopsy.
Lehman CD; Deperi ER; Peacock S; McDonough MD; Demartini WB; Shook J
AJR Am J Roentgenol; 2005 Jun; 184(6):1782-7. PubMed ID: 15908530
[TBL] [Abstract][Full Text] [Related]
53. Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance.
Philpotts LE; Shaheen NA; Jain KS; Carter D; Lee CH
Radiology; 2000 Sep; 216(3):831-7. PubMed ID: 10966718
[TBL] [Abstract][Full Text] [Related]
54. The significance of lobular carcinoma in situ and atypical lobular hyperplasia of the breast.
Lewis JL; Lee DY; Tartter PI
Ann Surg Oncol; 2012 Dec; 19(13):4124-8. PubMed ID: 22847126
[TBL] [Abstract][Full Text] [Related]
55. Percutaneous large-core biopsy of papillary breast lesions.
Liberman L; Bracero N; Vuolo MA; Dershaw DD; Morris EA; Abramson AF; Rosen PP
AJR Am J Roentgenol; 1999 Feb; 172(2):331-7. PubMed ID: 9930777
[TBL] [Abstract][Full Text] [Related]
56. Papillary lesions of the breast: impact of breast pathology subspecialization on core biopsy and excision diagnoses.
Jakate K; De Brot M; Goldberg F; Muradali D; O'Malley FP; Mulligan AM
Am J Surg Pathol; 2012 Apr; 36(4):544-51. PubMed ID: 22314186
[TBL] [Abstract][Full Text] [Related]
57. The management of lobular neoplasia identified on percutaneous core breast biopsy.
Bauer VP; Ditkoff BA; Schnabel F; Brenin D; El-Tamer M; Smith S
Breast J; 2003; 9(1):4-9. PubMed ID: 12558663
[TBL] [Abstract][Full Text] [Related]
58. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
59. Is surgical excision necessary for focal atypical ductal hyperplasia found at stereotactic vacuum-assisted breast biopsy?
Eby PR; Ochsner JE; DeMartini WB; Allison KH; Peacock S; Lehman CD
Ann Surg Oncol; 2008 Nov; 15(11):3232-8. PubMed ID: 18696163
[TBL] [Abstract][Full Text] [Related]
60. Outcome of MRI-guided breast biopsy.
Han BK; Schnall MD; Orel SG; Rosen M
AJR Am J Roentgenol; 2008 Dec; 191(6):1798-804. PubMed ID: 19020252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
